Concepedia

Heather Lynaugh

HL

Statistics

Publications

17

Citations

1.6K

H-Index

16

Active since

2008

Affiliations

Adimab (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Palo Alto Institute

Massachusetts Institute of Technology

Carterra (United States)

Heather Lynaugh is an author at Adimab (United States) specializing in pharmacy, antibody characterization, and monoclonal antibodies.

Publications per year

2008–2020

17

Publications

17

Biophysical properties of the clinical-stage antibody landscape

Tushar Jain, Tingwan Sun, Stéphanie Durand et al. · Proceedings of the National Academy of Sciences · 2017 · 634 citations · Full text

, , +17

Production of monoclonal antibodies by glycoengineered Pichia pastoris

Thomas I. Potgieter, Michael Cukan, J. E. Drummond et al. · Journal of Biotechnology · 2008 · 162 citations

, , +14

Deamidation and isomerization liability analysis of 131 clinical-stage antibodies

Xiaojun Lu, R. Paul Nobrega, Heather Lynaugh et al. · mAbs · 2018 · 148 citations · Full text

, , +17

Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability

Laila Shehata, Daniel P. Maurer, Anna Z. Wec et al. · Cell Reports · 2019 · 106 citations · Full text

, , +16

High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice

Ryan L. Kelly, Tingwan Sun, Tushar Jain et al. · mAbs · 2015 · 93 citations · Full text

, , +17

1–5 of 17